Vascular endothelial growth factor binding

Fibroblast growth factor-2 binds to fibrin specifically at two classes of binding sites and has striking effects on endothelial cell proliferation (Sahni et al., 1998, 1999). Vascular endothelial growth factor binds... 

Sahni, A., and Francis, C. W. (2000). Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Bbod 96, 3772-3778. 

Mitsi M, Hong Z, Costello CE. Nugent MA, Heparin-mediated conformational changes in fibronectin expose vascular endothelial growth factor binding sites. Biochemistry 2006 45 10319-10328. 

Wijelath, E.S., Rahman, S., Namekata, M., Murray, J., Nishimura, T., Mostafavi-Pour, Z., Patel, Y., Suda, Y., Humphries, M.J., Sobel, M., 2006. Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism. Circ. Res. 99 (8), 853-860. 

Placenta growth factor is a vascular endothelial growth factor (VEGF)-related molecule, which binds to VEGF-R1. 

Ferrara N, Damico L, Shams N, et al (2006) Developmemt of Ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Retina 26 859-870... 

Bevacizumab is a humanized monoclonal antibody that binds to vascular endothelial growth factor, which prevents it from binding to its receptors, ultimately resulting in angiogenesis. 

L, Zinkewich-Peotti K, Jayson GC (2007) Phase I evaluation of CDP791, a PEGylated di-Fab conjugate that binds vascular endothelial growth factor receptor 2. Clin Cancer Res 13 7113-7118... 

The antibody brings about its effect by inhibiting angiogenesis (the formation of new blood vessels), a process required to support tumour growth. Specifically, the antibody binds human vascular endothelial growth factor. This prevents the latter from binding to its cell surface receptor, a process central to triggering new blood vessel formation in both normal and diseased tissue. 

Mechanism of Action-. A selective vascular endothelial growth factor (VEGF) antagonize that selectively binds and activates receptors located on the surface of vascular endothelial cells. Therapeutic Effect Blocks angiogenesis and vascular permeability and inflammation which contribute to the progression of the neovascular (wet) form of age-related macular degeneration (AMD). 

---